Group One Trading’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-18,669
| Closed | -$8K | – | 5802 |
|
|
2018
Q4 | $8K | Buy |
18,669
+12,000
| +180% | +$7.46K | ﹤0.01% | 4370 |
|
|
2018
Q3 | $6K | Sell |
6,669
-3,852
| -37% | -$6.44K | ﹤0.01% | 4810 |
|
|
2018
Q2 | $26K | Buy |
10,521
+936
| +10% | +$2.29K | ﹤0.01% | 4280 |
|
|
2018
Q1 | $23K | Sell |
9,585
-3,535
| -27% | -$8.92K | ﹤0.01% | 4041 |
|
|
2017
Q4 | $31K | Hold |
13,120
| – | – | ﹤0.01% | 3976 |
|
|
2017
Q3 | $41K | Buy |
+13,120
| New | +$42.1K | ﹤0.01% | 3744 |
|
|
2017
Q2 | – | Sell |
-19,945
| Closed | -$86.9K | – | 5479 |
|
|
2017
Q1 | $74K | Buy |
19,945
+11,703
| +142% | +$36.7K | ﹤0.01% | 3181 |
|
|
2016
Q4 | $16K | Buy |
+8,242
| New | +$29.8K | ﹤0.01% | 3802 |
|
|
2016
Q2 | – | Sell |
-30
| Closed | -$196 | – | 5250 |
|
|
2016
Q1 | $0 | Sell |
30
-937
| -97% | -$18.6K | ﹤0.01% | 5354 |
|
|
2015
Q4 | $29K | Sell |
967
-3,549
| -79% | -$107K | ﹤0.01% | 3736 |
|
|
2015
Q3 | $143K | Sell |
4,516
-300
| -6% | -$14.4K | ﹤0.01% | 2769 |
|
|
2015
Q2 | $285K | Buy |
+4,816
| New | +$340K | ﹤0.01% | 2270 |
|
|
2015
Q1 | – | Sell |
-1,357
| Closed | -$129K | – | 5541 |
|
|
2014
Q4 | $127K | Buy |
1,357
+1,247
| +1,134% | +$119K | ﹤0.01% | 2668 |
|
|
2014
Q3 | $8K | Buy |
+110
| New | +$8.66K | ﹤0.01% | 4587 |
|
|
2013
Q4 | – | Sell |
-37
| Closed | -$1K | – | 5780 |
|
|
2013
Q3 | $1K | Hold |
37
| – | – | ﹤0.01% | 5060 |
|
|
2013
Q2 | $1K | Buy |
+37
| New | +$1.39K | ﹤0.01% | 4987 |
|
Group One Trading's PTX Position: Q1 2019 in Review
Group One Trading sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 18,669 shares — an estimated $8K sold.
Group One Trading first reported a position in PTX in Q2 2013 and held it in 16 quarters. The position peaked at $285K in Q2 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Group One Trading reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Group One Trading sold 18,669 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $8K.
- Group One Trading first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 16 quarters.
- Group One Trading's Pernix Therapeutics Holdings, Inc. position peaked at $285K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.